S&P 500   4,341.58 (-1.38%)
DOW   34,177.87 (-0.76%)
QQQ   359.08 (-1.50%)
AAPL   174.61 (-0.50%)
MSFT   320.39 (-0.12%)
META   296.86 (-0.94%)
GOOGL   131.03 (-2.03%)
AMZN   129.95 (-3.95%)
TSLA   256.67 (-2.25%)
NVDA   411.62 (-2.55%)
NIO   8.50 (-3.63%)
BABA   84.29 (-1.69%)
AMD   96.21 (-4.12%)
T   15.39 (-1.03%)
F   12.26 (-0.81%)
MU   68.31 (-1.97%)
CGC   0.79 (-9.53%)
GE   113.63 (-1.06%)
DIS   82.68 (+0.15%)
AMC   7.74 (-5.15%)
PFE   32.97 (-1.93%)
PYPL   58.92 (-3.19%)
NFLX   384.59 (-0.44%)
S&P 500   4,341.58 (-1.38%)
DOW   34,177.87 (-0.76%)
QQQ   359.08 (-1.50%)
AAPL   174.61 (-0.50%)
MSFT   320.39 (-0.12%)
META   296.86 (-0.94%)
GOOGL   131.03 (-2.03%)
AMZN   129.95 (-3.95%)
TSLA   256.67 (-2.25%)
NVDA   411.62 (-2.55%)
NIO   8.50 (-3.63%)
BABA   84.29 (-1.69%)
AMD   96.21 (-4.12%)
T   15.39 (-1.03%)
F   12.26 (-0.81%)
MU   68.31 (-1.97%)
CGC   0.79 (-9.53%)
GE   113.63 (-1.06%)
DIS   82.68 (+0.15%)
AMC   7.74 (-5.15%)
PFE   32.97 (-1.93%)
PYPL   58.92 (-3.19%)
NFLX   384.59 (-0.44%)
S&P 500   4,341.58 (-1.38%)
DOW   34,177.87 (-0.76%)
QQQ   359.08 (-1.50%)
AAPL   174.61 (-0.50%)
MSFT   320.39 (-0.12%)
META   296.86 (-0.94%)
GOOGL   131.03 (-2.03%)
AMZN   129.95 (-3.95%)
TSLA   256.67 (-2.25%)
NVDA   411.62 (-2.55%)
NIO   8.50 (-3.63%)
BABA   84.29 (-1.69%)
AMD   96.21 (-4.12%)
T   15.39 (-1.03%)
F   12.26 (-0.81%)
MU   68.31 (-1.97%)
CGC   0.79 (-9.53%)
GE   113.63 (-1.06%)
DIS   82.68 (+0.15%)
AMC   7.74 (-5.15%)
PFE   32.97 (-1.93%)
PYPL   58.92 (-3.19%)
NFLX   384.59 (-0.44%)
S&P 500   4,341.58 (-1.38%)
DOW   34,177.87 (-0.76%)
QQQ   359.08 (-1.50%)
AAPL   174.61 (-0.50%)
MSFT   320.39 (-0.12%)
META   296.86 (-0.94%)
GOOGL   131.03 (-2.03%)
AMZN   129.95 (-3.95%)
TSLA   256.67 (-2.25%)
NVDA   411.62 (-2.55%)
NIO   8.50 (-3.63%)
BABA   84.29 (-1.69%)
AMD   96.21 (-4.12%)
T   15.39 (-1.03%)
F   12.26 (-0.81%)
MU   68.31 (-1.97%)
CGC   0.79 (-9.53%)
GE   113.63 (-1.06%)
DIS   82.68 (+0.15%)
AMC   7.74 (-5.15%)
PFE   32.97 (-1.93%)
PYPL   58.92 (-3.19%)
NFLX   384.59 (-0.44%)
Followed 110 TimesTop Followed
NYSE:ABBV

AbbVie (ABBV) News Today

$153.72
+0.11 (+0.07%)
(As of 03:10 PM ET)
Compare
Today's Range
$152.66
▼
$154.85
50-Day Range
$133.56
▼
$153.93
52-Week Range
$130.96
▼
$168.11
Volume
1.94 million shs
Average Volume
5.62 million shs
Market Capitalization
$271.32 billion
P/E Ratio
31.63
Dividend Yield
3.85%
Price Target
$165.79
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability
SourceHeadline
finance.yahoo.com logo3 Bargain Stocks to Buy in a Market That's Priced for Perfection
finance.yahoo.com - September 21 at 2:56 PM
msn.com logoUS pharma group AbbVie opens new €23m Dublin facility
msn.com - September 21 at 9:55 AM
finance.yahoo.com logoAbbVie (NYSE:ABBV) Has A Pretty Healthy Balance Sheet
finance.yahoo.com - September 21 at 9:55 AM
marketbeat.com logoAbbVie Inc. (NYSE:ABBV) Shares Sold by Redhawk Wealth Advisors Inc.
marketbeat.com - September 21 at 7:36 AM
marketbeat.com logoThis Proven 200% Dividend Growth Strategy Is a Peter Lynch Favorite
marketbeat.com - September 20 at 10:03 PM
benzinga.com logoLeading Players Pfizer, AbbVie, and Novartis at the Forefront of Advancements in Plaque Psoriasis Treatment
benzinga.com - September 20 at 6:29 PM
marketwatch.com logoAbbVie Inc. stock outperforms market on strong trading day
marketwatch.com - September 20 at 6:29 PM
marketbeat.com logoSymphony Financial Ltd. Co. Has $967,000 Holdings in AbbVie Inc. (NYSE:ABBV)
marketbeat.com - September 20 at 7:24 AM
marketbeat.com logoFlee to Healthcare Stocks if Recession Rears its Head? (ABBV)
marketbeat.com - September 20 at 7:04 AM
finance.yahoo.com logoFormer IBD 50 Stock Revance Implodes As Its 'Prestige' Plan Goes Up In Smoke
finance.yahoo.com - September 19 at 2:56 PM
marketbeat.com logoAbbVie Inc. (NYSE:ABBV) Shares Sold by MJP Associates Inc. ADV
marketbeat.com - September 19 at 7:40 AM
stocknews.com logo3 Healthcare Stocks to Buy Today
stocknews.com - September 18 at 9:06 PM
marketwatch.com logoAbbVie's Botox Meets Key Goals in 2nd Platysma Prominence Study
marketwatch.com - September 18 at 1:39 PM
msn.com logoAbbVie: Company Vs. Stock, A Gentle Facelift Would Be Nice (Technical Analysis)
msn.com - September 18 at 1:39 PM
msn.com logoAbbvie (ABBV) Declares $1.48 Dividend
msn.com - September 17 at 2:01 PM
marketbeat.com logoFoster Group Inc. Sells 715 Shares of AbbVie Inc. (NYSE:ABBV)
marketbeat.com - September 17 at 7:48 AM
finance.yahoo.com logoAbbVie (ABBV) Fell in Q2 Due to Competition
finance.yahoo.com - September 15 at 10:04 AM
marketbeat.com logoArmstrong Advisory Group Inc. Cuts Stock Position in AbbVie Inc. (NYSE:ABBV)
marketbeat.com - September 15 at 8:44 AM
barrons.com logoAbbVie Inc.
barrons.com - September 14 at 10:52 PM
morningstar.com logoAbbVie Currently Up Six Consecutive Days, On Track for Longest Winning Streak Since March 2022 — Data Talk
morningstar.com - September 14 at 5:51 PM
marketbeat.com logoDuality Advisers LP Invests $5.30 Million in AbbVie Inc. (NYSE:ABBV)
marketbeat.com - September 14 at 8:57 AM
finance.yahoo.com logoZacks Investment Ideas feature highlights: Novo Nordisk, Eli Lilly and AbbVie
finance.yahoo.com - September 14 at 7:50 AM
stocknews.com logo3 A-Rated Pharma Stocks to Buy Today
stocknews.com - September 13 at 6:19 PM
benzinga.com logoAbbVie Unusual Options Activity For September 13
benzinga.com - September 13 at 4:49 PM
marketwatch.com logoHarpoon Shares Drop 7.3% as AbbVie Declines License Option
marketwatch.com - September 13 at 4:49 PM
finance.yahoo.com logoAbbVie's (ABBV) Skyrizi Crohn's Disease Study Meets Goals
finance.yahoo.com - September 13 at 4:49 PM
finance.yahoo.com logoAbbVie Calls on Public to Vote for the 2023 AbbVie Cystic Fibrosis Scholarship "Thriving Students"
finance.yahoo.com - September 13 at 4:49 PM
seekingalpha.com logoAbbVie Inc. (ABBV) Management Presents at Morgan Stanley 21st Annual Global Healthcare Brokers Conference 2023 (Transcript)
seekingalpha.com - September 13 at 4:01 PM
marketbeat.com logoEmpower Advisory Group LLC Buys Shares of 484,104 AbbVie Inc. (NYSE:ABBV)
marketbeat.com - September 13 at 11:39 AM
markets.businessinsider.com logoAbbVie (ABBV) Gets a Hold from Goldman Sachs
markets.businessinsider.com - September 12 at 11:15 PM
markets.businessinsider.com logoAbbVie Reports Top-line Results From Phase 3 SEQUENCE Clinical Trial Of Risankizumab
markets.businessinsider.com - September 12 at 6:14 PM
finance.yahoo.com logoIs AbbVie (ABBV) a Buy as Wall Street Analysts Look Optimistic?
finance.yahoo.com - September 12 at 6:14 PM
marketbeat.com logoStrategic Global Advisors LLC Sells 5,720 Shares of AbbVie Inc. (NYSE:ABBV)
marketbeat.com - September 12 at 1:43 PM
marketbeat.com logoHigh Yield, Low Beta Stocks to Buy for the Next Market Meltdown (ABBV)
marketbeat.com - September 12 at 7:10 AM
finance.yahoo.com logoShould You Hold AbbVie (ABBV)?
finance.yahoo.com - September 11 at 5:14 PM
benzinga.com logo(ABBV) - Analyzing AbbVie's Short Interest
benzinga.com - September 10 at 10:39 PM
finance.yahoo.com logoPossible Bearish Signals With AbbVie Insiders Disposing Stock
finance.yahoo.com - September 10 at 4:42 PM
marketbeat.com logoAbbVie Inc. (NYSE:ABBV) Shares Sold by Ensign Peak Advisors Inc
marketbeat.com - September 10 at 1:50 PM
marketbeat.com logoVeritable L.P. Cuts Position in AbbVie Inc. (NYSE:ABBV)
marketbeat.com - September 8 at 3:43 PM
finance.yahoo.com logoAlector (ALEC) Up 7% on Finishing Enrolment in Alzheimer Study
finance.yahoo.com - September 8 at 2:51 PM
marketbeat.com logoAbbVie Inc. Plans Quarterly Dividend of $1.48 (NYSE:ABBV)
marketbeat.com - September 8 at 12:53 PM
marketbeat.com logoStifel Financial Corp Sells 248,671 Shares of AbbVie Inc. (NYSE:ABBV)
marketbeat.com - September 7 at 4:18 PM
finance.yahoo.com logoAlector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease
finance.yahoo.com - September 7 at 7:10 AM
finance.yahoo.com logoJoin BOTOX® Cosmetic (onabotulinumtoxinA) and IFundWomen in Supporting Women Entrepreneurs
finance.yahoo.com - September 6 at 9:59 AM
msn.com logoUK MHRA approves AbbVie’s migraine prevention drug Aquipta
msn.com - September 5 at 1:58 PM
insidermonkey.com logoHere’s Why AbbVie (ABBV) Declined in Q2
insidermonkey.com - September 5 at 1:58 PM
msn.com logoAbbVie Unleashed: 4% Yield, Potentially 40% Undervalued
msn.com - September 4 at 6:27 PM
stocknews.com logoTop 3 Pharma Stocks to Boost Your Portfolio
stocknews.com - September 4 at 3:11 PM
seekingalpha.com logoAbbVie: Proving The Bears Wrong Again As Shares Surged
seekingalpha.com - September 4 at 2:09 PM
msn.com logoAbbVie: Balance Is Everything
msn.com - September 4 at 2:15 AM
Get AbbVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter.



ABBV Media Mentions By Week

ABBV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABBV
News Sentiment
▼
0.78

0.46
▲
Average
Medical
News Sentiment

ABBV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABBV Articles
This Week
▼
20

16
▲
ABBV Articles
Average Week

Get AbbVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NYSE:ABBV) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -